AbCellera Biologics Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -2.21M124.16M153.46M158.52M-146.40M-162.86M
Depreciation and Depletion 1.60M2.32M4.40M9.00M12.80M12.54M
Share-based Compensation 0.89M8.40M30.65M49.48M64.18M67.58M
Deferred Taxes 2.10M-2.02M-2.11M1.96M
Gains from Investment Securities -0.19M19.25M30.32M25.68M13.69M19.71M
Non-cash Items 0.10M113.40M
Cash from Operations 2.69M22.69M244.58M277.36M-43.88M-108.56M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.24M2.52M10.06M18.89M11.64M78.31M
Depreciation & Amortization (CF) 1.60M2.32M4.40M9.00M12.80M12.54M
Change in Working Capital
Change in Receivables 1.80M5.47M37.39M22.71M45.93M75.12M
Change in Account Payables 0.15M27.14M-4.64M-3.16M
Change in Accured Expenses -2.09M-15.10M10.63M
Change in Taxes 36.41M-13.53M-88.61M30.46M6.65M
Investing Activities
Capital Expenditures 4.00M9.67M58.45M70.66M76.95M78.40M
Change in Intangibles 5.00M2.00M0.56M
Acquisitions 87.64M11.46M
Change in Acquisitions & Divestments 27.61M510.63M910.94M937.88M
Cash from Investing Activities -5.78M-119.78M-332.25M-352.62M-221.11M121.41M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances 0.19M15.49M0.87M
Long-Term Debt Repayments 0.40M19.94M1.82M
Short-Term Debt issuances 0.39M-0.39M
Change in Capital Stock
Shares Issued 0.03M522.84M4.62M
Preferred Shares Issued -0.01M74.66M
Misc.
Cash from Financing Activities 0.20M683.65M-3.89M-1.63M10.36M12.77M
Exchange Rate Effect -1.43M-9.60M0.59M-2.62M
Change in Cash -2.89M586.56M-92.97M-86.49M-254.04M23.00M
Free Cash Flow -1.30M13.02M186.13M206.70M-120.82M-186.95M
Net Cash Flow -2.89M586.56M-91.55M-76.89M-254.63M25.62M